Most lately, it has been discovered that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to some big range of endogenous opioids. In contrast to most opioid receptors, this receptor functions being a scavenger and would not activate a 2nd